Virtu Financial LLC Evogene Ltd. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$0.7 - $0.98 $8,066 - $11,293	11,524 New	11,524 $9,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $1.41 $9,122 - $22,176	-15,728 Reduced 57.54%	11,605 $7,000
Q2 2023 Jul 27, 2023	BUY	$0.56 - $1.2 $15,306 - $32,799	27,333 New	27,333 $29,000
Q3 2022 Nov 07, 2022	BUY	$0.73 - $8.65 $11,161 - $132,258	15,290 New	15,290 $13,000
Q2 2022 Aug 09, 2022	SELL	$0.75 - $1.33 $27,432 - $48,646	-36,576 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$1.09 - $1.83 $39,867 - $66,934	36,576 New	36,576 $48,000
Q1 2021 May 19, 2021	SELL	$4.29 - $9.94 $227,507 - $527,138	-53,032 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$2.41 - $5.63 $127,807 - $298,570	53,032 New	53,032 $249,000
Q3 2020 Dec 11, 2020	SELL	$0.97 - $4.08 $14,961 - $62,929	-15,424 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$0.92 - $1.29 $14,190 - $19,896	15,424 New	15,424 $15,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $69.6M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.